RU94038546ARU94038546/14ARU94038546ARU94038546ARU 94038546 ARU94038546 ARU 94038546ARU 94038546/14 ARU94038546/14 ARU 94038546/14ARU 94038546 ARU94038546 ARU 94038546ARU 94038546 ARU94038546 ARU 94038546A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное общество закрытого типа "Апика"filedCriticalАкционерное общество закрытого типа "Апика"
Priority to RU94038546ApriorityCriticalpatent/RU2125867C1/en
Publication of RU94038546ApublicationCriticalpatent/RU94038546A/en
Application grantedgrantedCritical
Publication of RU2125867C1publicationCriticalpatent/RU2125867C1/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Medicinal Preparation
(AREA)
Abstract
FIELD: medicine, dermatology, pharmacy. SUBSTANCE: ointment containing propolis and hydrophobic hydrocarbon base has additionally ethanol, glycerol and beeswax at the following ratio of components, weight %: propolis (measured as dry matter) 1-9; ethyl alcohol 12-28; hydrophobic hydrocarbon base 36-60; beeswax 18, and glycerol 9. Ointment can be used for treatment of the broad diseases spectrum. EFFECT: improved property of ointment, enhanced effectiveness.
Claims (1)
Изобретение относится к медицине, в частности к прополисной мази. Задача изобретения - создание стабильной мази, используемой для лечения широкого спектра заболеваний. Поставленная задача достигается тем, что кроме прополиса и гидрофобной углеводородной основы, она дополнительно содержит этиловый спирт, глицерин и пчелиный воск, при следующих соотношениях компонентов, вес.%: прополис (в пересчете на сухие вещества) 1 - 9; этиловый спирт 12 - 28; гидрофобная углеводородная основа 36 - 60; пчелиный воск 18; глицерин 9.The invention relates to medicine, in particular to propolis ointment. The objective of the invention is the creation of a stable ointment used to treat a wide range of diseases. The problem is achieved in that in addition to propolis and a hydrophobic hydrocarbon base, it additionally contains ethyl alcohol, glycerin and beeswax, with the following ratio of components, wt.%: Propolis (in terms of solids) 1 - 9; ethyl alcohol 12 - 28; hydrophobic hydrocarbon base 36 to 60; beeswax 18; glycerin 9.
Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage